Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells. [electronic resource]
Producer: 20130128Description: 530-41 p. digitalISSN:- 1878-0261
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Synergism
- Endometrial Neoplasms -- drug therapy
- Endometrium -- drug effects
- Female
- Humans
- Indoles -- pharmacology
- NF-kappa B -- antagonists & inhibitors
- Pyrazines -- pharmacology
- Pyrroles -- pharmacology
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.